34 results
8-K
EX-1.1
MNPR
Monopar Therapeutics Inc
20 Apr 22
Entry into a Material Definitive Agreement
5:23pm
been no security breach or incident, unauthorized access or disclosure, or other compromise of or relating to the Company’s or its Subsidiaries … effective applicable provisions of the Sarbanes-Oxley Act.
8. Payment of Expenses. The Company will pay all expenses incident to the performance of its
DEF 14A
15ua6h5ijj42ryg 4m2c
29 Apr 20
Definitive proxy
12:57pm
8-K
EX-1
g7u071na
13 Jan 20
Entry into a Material Definitive Agreement
4:09pm
424B4
9wmtjgfo
19 Dec 19
Prospectus supplement with pricing info
5:36pm
S-1/A
EX-10.4
sqari bd84ibd4vd
10 Sep 19
IPO registration (amended)
5:23pm